Factors associated with fatigue in CNS inflammatory diseases with AQP4 and MOG antibodies
OBJECTIVE:Fatigue is a common and disabling symptom amongst people with multiple sclerosis, however it has not been compared across the central nervous system (CNS) inflammatory diseases associated with aquaporin-4 (AQP4) and myelin oligodendrocyte glycoprotein (MOG) antibodies (Ab). We explored the...
| Príomhchruthaitheoirí: | , , , , , , , , |
|---|---|
| Formáid: | Journal article |
| Teanga: | English |
| Foilsithe / Cruthaithe: |
Wiley
2020
|
| _version_ | 1826303946030841856 |
|---|---|
| author | Yeo, T Dos Passos, GR Muhammed, L Everett, R Reeve, S Messina, S Probert, F Leite, MI Jacqueline Palace |
| author_facet | Yeo, T Dos Passos, GR Muhammed, L Everett, R Reeve, S Messina, S Probert, F Leite, MI Jacqueline Palace |
| author_sort | Yeo, T |
| collection | OXFORD |
| description | OBJECTIVE:Fatigue is a common and disabling symptom amongst people with multiple sclerosis, however it has not been compared across the central nervous system (CNS) inflammatory diseases associated with aquaporin-4 (AQP4) and myelin oligodendrocyte glycoprotein (MOG) antibodies (Ab). We explored the factors associated with fatigue within and across the two diseases, and compared fatigue levels between them.
<br><br>
METHODS:We performed a cross-sectional study of 90 AQP4-Ab and 44 MOG-Ab patients. Fatigue was assessed using the Modified Fatigue Impact Scale (MFIS). Clinical, demographic, and psychometric (anxiety, depression, pain) data were used as independent variables. Multivariable linear regression was used to identify significant independent variables associated with fatigue within and across the two diseases.
<br><br>
RESULTS:Within AQP4-Ab patients, age (P = 0.002), disease duration (P = 0.004), number of clinical attacks (P = 0.001), disability (P = 0.007), pain interference (P < 0.001), anxiety (P = 0.026), and depression (P < 0.001) were significant independent variables. Interestingly, disease duration had a negative association with fatigue (P = 0.004). Within MOG-Ab patients, pain interference score (P < 0.001) and anxiety (P = 0.001) were significant independent variables. Although fatigue was worse in AQP4-Ab patients compared to MOG-Ab patients (P = 0.008) in all patients as well as in those who ever had transverse myelitis (P = 0.023), this was driven by the differences in age, disability and pain interference rather than antibody subtype itself.
<br><br>
INTERPRETATION:Multiple factors, but not the antibody specificity, appear to contribute to fatigue in antibody positive CNS inflammatory diseases. A multifaceted treatment approach is needed to better manage the physical, cognitive, and psychosocial aspects of fatigue in these patients. |
| first_indexed | 2024-03-07T06:10:23Z |
| format | Journal article |
| id | oxford-uuid:ef49c0b9-aa14-441c-baf7-68bf87d9f46e |
| institution | University of Oxford |
| language | English |
| last_indexed | 2024-03-07T06:10:23Z |
| publishDate | 2020 |
| publisher | Wiley |
| record_format | dspace |
| spelling | oxford-uuid:ef49c0b9-aa14-441c-baf7-68bf87d9f46e2022-03-27T11:39:08ZFactors associated with fatigue in CNS inflammatory diseases with AQP4 and MOG antibodiesJournal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:ef49c0b9-aa14-441c-baf7-68bf87d9f46eEnglishSymplectic ElementsWiley2020Yeo, TDos Passos, GRMuhammed, LEverett, RReeve, SMessina, SProbert, FLeite, MIJacqueline PalaceOBJECTIVE:Fatigue is a common and disabling symptom amongst people with multiple sclerosis, however it has not been compared across the central nervous system (CNS) inflammatory diseases associated with aquaporin-4 (AQP4) and myelin oligodendrocyte glycoprotein (MOG) antibodies (Ab). We explored the factors associated with fatigue within and across the two diseases, and compared fatigue levels between them. <br><br> METHODS:We performed a cross-sectional study of 90 AQP4-Ab and 44 MOG-Ab patients. Fatigue was assessed using the Modified Fatigue Impact Scale (MFIS). Clinical, demographic, and psychometric (anxiety, depression, pain) data were used as independent variables. Multivariable linear regression was used to identify significant independent variables associated with fatigue within and across the two diseases. <br><br> RESULTS:Within AQP4-Ab patients, age (P = 0.002), disease duration (P = 0.004), number of clinical attacks (P = 0.001), disability (P = 0.007), pain interference (P < 0.001), anxiety (P = 0.026), and depression (P < 0.001) were significant independent variables. Interestingly, disease duration had a negative association with fatigue (P = 0.004). Within MOG-Ab patients, pain interference score (P < 0.001) and anxiety (P = 0.001) were significant independent variables. Although fatigue was worse in AQP4-Ab patients compared to MOG-Ab patients (P = 0.008) in all patients as well as in those who ever had transverse myelitis (P = 0.023), this was driven by the differences in age, disability and pain interference rather than antibody subtype itself. <br><br> INTERPRETATION:Multiple factors, but not the antibody specificity, appear to contribute to fatigue in antibody positive CNS inflammatory diseases. A multifaceted treatment approach is needed to better manage the physical, cognitive, and psychosocial aspects of fatigue in these patients. |
| spellingShingle | Yeo, T Dos Passos, GR Muhammed, L Everett, R Reeve, S Messina, S Probert, F Leite, MI Jacqueline Palace Factors associated with fatigue in CNS inflammatory diseases with AQP4 and MOG antibodies |
| title | Factors associated with fatigue in CNS inflammatory diseases with AQP4 and MOG antibodies |
| title_full | Factors associated with fatigue in CNS inflammatory diseases with AQP4 and MOG antibodies |
| title_fullStr | Factors associated with fatigue in CNS inflammatory diseases with AQP4 and MOG antibodies |
| title_full_unstemmed | Factors associated with fatigue in CNS inflammatory diseases with AQP4 and MOG antibodies |
| title_short | Factors associated with fatigue in CNS inflammatory diseases with AQP4 and MOG antibodies |
| title_sort | factors associated with fatigue in cns inflammatory diseases with aqp4 and mog antibodies |
| work_keys_str_mv | AT yeot factorsassociatedwithfatigueincnsinflammatorydiseaseswithaqp4andmogantibodies AT dospassosgr factorsassociatedwithfatigueincnsinflammatorydiseaseswithaqp4andmogantibodies AT muhammedl factorsassociatedwithfatigueincnsinflammatorydiseaseswithaqp4andmogantibodies AT everettr factorsassociatedwithfatigueincnsinflammatorydiseaseswithaqp4andmogantibodies AT reeves factorsassociatedwithfatigueincnsinflammatorydiseaseswithaqp4andmogantibodies AT messinas factorsassociatedwithfatigueincnsinflammatorydiseaseswithaqp4andmogantibodies AT probertf factorsassociatedwithfatigueincnsinflammatorydiseaseswithaqp4andmogantibodies AT leitemi factorsassociatedwithfatigueincnsinflammatorydiseaseswithaqp4andmogantibodies AT jacquelinepalace factorsassociatedwithfatigueincnsinflammatorydiseaseswithaqp4andmogantibodies |